Indian medical device manufacturer Meril has lodged a challenge in court seeking to invalidate two patents currently safeguarding the design of prosthetic heart valves. These patents belong to Edwards Lifesciences, a company which has levelled infringement claims against Meril spanning five jurisdictions.
Edwards Lifesciences, a known player in the MedTech business, owns patents that protect specific designs of prosthetic heart valves. The infringing allegations against Meril, extended across multiple regions, reverberate a high-stakes patent battle in the medical device industry.
The court’s decision will indeed have significant ramifications in the MedTech patent landscape. A move like this by Meril suggests that the company is not backing down in the face of multiple jurisdictions filing infringement claims against them.
The complexities of this case underscore the challenging nature of patent claims and disputes in the intensely competitive MedTech field.
For an in-depth look into the matter, visit the original article on
Law360.